Orally available compound prevents deficits in memory caused by the Alzheimer amyloid-β oligomers

Objective Despite progress in defining a pathogenic role for amyloid β protein (Aβ) in Alzheimer's disease, orally bioavailable compounds that prevent its effects on hippocampal synaptic plasticity and cognitive function have not yet emerged. A particularly attractive therapeutic strategy is to...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Annals of neurology 2006-12, Vol.60 (6), p.668-676
Hauptverfasser: Townsend, Matthew, Cleary, James P., Mehta, Tapan, Hofmeister, Jacki, Lesne, Sylvain, O'Hare, Eugene, Walsh, Dominic M., Selkoe, Dennis J.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!